Skip to main content
. 2024 Jan 15;16(2):369. doi: 10.3390/cancers16020369
PD-1/PD-L1 programmed death 1/ligand 1
CTLA-4 cytotoxic T-lymphocyte antigen 4
irAE immune-related adverse event
CTCAEv5 Common Terminology Criteria for Adverse Events version 5
SIT selective immunosuppressive therapy